Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Jones

Showing results (781-790 of 3,162) with videos related to

Pageof 317
Sort By:
Diagnostic Microbiology and Infectious Disease|May 1, 1985
BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agentsR N Jones, A L Barry, R R Packer
Placenta|April 13, 2022
Interventions for placental insufficiency and fetal growth restrictionBaylea N Davenport, Rebecca L Wilson, Helen N Jones
International Journal of Antimicrobial Agents|January 1, 2003
Sustained activity and spectrum of selected extended-spectrum beta-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997-2000)Ronald N Jones, Douglas J Biedenbach, Ana C Gales
Diagnostic Microbiology and Infectious Disease|January 5, 2002
Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA)M A Pfaller, R N Jones, D J Biedenbach, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|November 20, 2001
Antimicrobial activity of linezolid against Gram-positive cocci isolated in BrazilH S Sader, A C Gales, R N Jones
Diagnostic Microbiology and Infectious Disease|September 12, 2003
Contemporary re-evaluation of the activity and spectrum of grepafloxacin tested against isolates in the United StatesKelley A Gordon, Helio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|June 19, 2003
Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniaeT R Anderegg, D J Biedenbach, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1987
Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteriaP C Fuchs, R N Jones, A L Barry
Assessment|January 15, 2021
Examining the Short Dark Tetrad (SD4) Across Models, Correlates, and GenderCraig S Neumann, Daniel N Jones, Delroy L Paulhus
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|January 7, 2022
Roles of maternal HDL during pregnancyLaura A Woollett, Janet M Catov, Helen N Jones
Pageof 317

Showing results (781-790 of 3,162) with videos related to

Sort By:
Pageof 317
Diagnostic Microbiology and Infectious Disease|May 1, 1985
BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agentsR N Jones, A L Barry, R R Packer
Placenta|April 13, 2022
Interventions for placental insufficiency and fetal growth restrictionBaylea N Davenport, Rebecca L Wilson, Helen N Jones
International Journal of Antimicrobial Agents|January 1, 2003
Sustained activity and spectrum of selected extended-spectrum beta-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997-2000)Ronald N Jones, Douglas J Biedenbach, Ana C Gales
Diagnostic Microbiology and Infectious Disease|January 5, 2002
Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA)M A Pfaller, R N Jones, D J Biedenbach, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|November 20, 2001
Antimicrobial activity of linezolid against Gram-positive cocci isolated in BrazilH S Sader, A C Gales, R N Jones
Diagnostic Microbiology and Infectious Disease|September 12, 2003
Contemporary re-evaluation of the activity and spectrum of grepafloxacin tested against isolates in the United StatesKelley A Gordon, Helio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|June 19, 2003
Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniaeT R Anderegg, D J Biedenbach, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1987
Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteriaP C Fuchs, R N Jones, A L Barry
Assessment|January 15, 2021
Examining the Short Dark Tetrad (SD4) Across Models, Correlates, and GenderCraig S Neumann, Daniel N Jones, Delroy L Paulhus
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|January 7, 2022
Roles of maternal HDL during pregnancyLaura A Woollett, Janet M Catov, Helen N Jones
Pageof 317